President & CEO - Kevin McMahon

Co-Founder, Parent of a child with type 1 diabetes, technologist and former member of the CDMA Steering Committee of the wireless industry.

Eric Link - Chief Technology Officer

Co-Founder, Recognized leader in the Open Source Software Development movement, Enterprise class technologist with experience at EDS and former Managing Partner of a high-end software development boutique.

Joe Capece - Vice President Corporate Dev.

Over 25 years assembling medical sales teams in cardiac monitoring, disease management and home health industries.

Stephen Ponder, MD CDE-Chief Med. Officer

Over 35 years experience with diabetes since diagnosis w type 1 at age 9. World renowned endocrinologist, Past Chair Natl Board of Certified Diabetes Educators, Prof. Medicine TX A&M, Medical Director Texas Lions Summer Camp for Kids w Diabetes...

Barbara J. Anderson, PhD

Barbara is a behavioral scientist and licensed clinical psychologist with 25 years of experience in diabetes research as well as in clinical work with youth with diabetes and their families. She has published extensively on the interplay of psycho-social and family factors with adherence and medical outcomes in youth with diabetes.

Dr. Anderson is currently involved with two multi-site NIH-funded trials - one with youth with type 1 and families and the other with youth with type 2 and families. Her research interest is on the development of effective strategies for integrating a family and a child development focus into the delivery of pediatric diabetes health care. Dr. Anderson is currently Professor of Pediatrics, Baylor College of Medicine, and Senior Psychologist, Diabetes Care Center, Texas Children's Hospital.

Sonia Cooper, President - Children With Diabetes Foundation

Sonia's sister has Type I diabetes, and her son was diagnosed when he was 1 1/2 years old. She has two other children participating in prevention trials. She has been actively donating, fund-raising, studying and reviewing Type I research projects for ten years. She previously served on the ADA and JDRF boards and helped to review research grants for the JDRF. She has a B.S. in Finance and an M.S. in Systems Management from the University of Southern California.

Barry J. Goldstein, MD, PhD

Professor of Medicine, Biochemistry and Molecular Pharmacology, Jefferson Medical College of Thomas Jefferson University

Director of the Division of Endocrinology, Diabetes and Metabolic Diseases, Thomas Jefferson University Hospital in Philadelphia, Pennsylvania

Dr. Goldstein received a Bachelor of Science degree with distinction from Cornell University in Ithaca, New York, where he concentrated in biochemistry and genetics, and graduated with honors from the Medical Scientist Training Program (MD/PhD Biochemistry) of the University of Rochester School of Medicine and Dentistry in Rochester, New York. Following a medical residency at Strong Memorial Hospital in Rochester, Dr. Goldstein completed research and clinical fellowships at Harvard Medical School in the Section on Cellular and Molecular Physiology of the Joslin Diabetes Center and in the Division of Endocrinology, Diabetes and Metabolism at Brigham and Women's Hospital in Boston. After serving as an Assistant Professor at Harvard and a Research Investigator in the Joslin Research Laboratories, Dr. Goldstein moved to Philadelphia, where he assumed his current role at Jefferson Medical College.

Dr. Goldstein maintains active basic and clinical research programs, with interests centered on the mechanisms and regulation of insulin signal transduction, especially the pathophysiology of insulin resistant disease states, including obesity and type 2 diabetes. Recently, his laboratory has been interested in the vascular signaling effects of the abundant adipose-specific secreted protein adiponectin. He has authored more than 150 papers in basic and clinical research, as well as reviews and textbook chapters. He is frequently invited to lecture at national conferences and international symposia.

Dr. Goldstein is a Fellow of the American College of Endocrinology (FACE), and has been elected to membership in the American Society for Clinical Investigation (ASCI), the Interurban Clinical Club and the Association of American Physicians (AAP). He is an Associate Editor for Diabetes and until recently also served as an Associate Editor of the Journal of Clinical Endocrinology and Metabolism and on the Editorial Board of Current Drug Targets in Immune, Endocrine & Metabolic Disorders. He is a past president of both the Philadelphia Endocrine Society and the Philadelphia Affiliate of the American Diabetes Association and a former member of the Subspecialty Board on Endocrinology, Diabetes and Metabolism of the American Board of Internal Medicine.

Fran Dramis

Mr. Dramis is a telecom industry veteran who brings to Diabetech vast knowledge and experience, having designed, built, and managed some of the largest, most complex, and secure service provider infrastructure in the world.

Mr. Dramis joined BellSouth Corporation in 1998 as CIO and led the IT organization as Chief Information, E- Commerce and Security Officer for the past eight years. Before joining BellSouth, Mr. Dramis worked with CIO Strategy, Inc., an information technology consulting firm. Prior to that time, Mr. Dramis was managing director and CIO at Salomon Brothers. Mr. Dramis also served as president and chief executive officer of Network Management and president and chief operating officer of Telic Corporation. Early in his career, Mr. Dramis worked with AT&T, including Bell Labs, rising to the position of executive director of information product management. In addition to serving on Diabetech's Advisory Board, Mr. Dramis currently serves on the Boards of RealOps, Avocent Corporation and webMethods.

"We're very excited to work with Fran as we develop our employer focused interventional programs," said Kevin McMahon, President & CEO of Diabetech. "Fran clearly understands the potential of technology and appreciates our unique participant-centric system for team management with support from friends, family, co-workers and their medical team. His first hand experience with this innovative approach will help us to communicate with employers struggling to control health care costs and for their employees, dependents and retirees looking for an innovative program that works."

Fran has been recognized by a variety of publications as a top CIO and IT leader. "As a former CIO, I have witnessed Diabetech's automated diabetes intervention programs in action. By integrating real-time wireless medical devices, rules based decision support and social networks, the long promised yet seldom delivered return on investment from disease management programs is here."

So advanced, it's simple.

• healthcordia is the Programs Division of Diabetech, LP
• See Diabetech's Corporate site for more information on devices